ScholarIQanswers from OpenAlex

Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis

PaperCitations, authors & open-access status

Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis have?

ScholarIQcitation count

Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis has 319 citations in the OpenAlex counts ScholarIQ stores.

When was Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis published?

ScholarIQyear

Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis has 2000 year in the ScholarIQ index.

What is the open-access status of Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis?

ScholarIQoa status

Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis has closed oa status in the ScholarIQ index.

What is the DOI of Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis?

ScholarIQdoi

The DOI for Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis is on the source record.

What is the PMID of Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis?

ScholarIQpmid

The PMID for Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis is on the source record.

What is the OpenAlex record for Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis?

ScholarIQopenalex

The OpenAlex for Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial